CA1247538A
(en)
*
|
1982-05-21 |
1988-12-28 |
Mark C. Glassy |
Human-human hybridomas for solid tumors
|
US4613576A
(en)
*
|
1983-03-09 |
1986-09-23 |
Sloan-Kettering Institute For Cancer Research |
Human monoclonal antibodies to cancer cells
|
US4634666A
(en)
*
|
1984-01-06 |
1987-01-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human-murine hybridoma fusion partner
|
EP0148644A3
(en)
*
|
1984-01-06 |
1987-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
A novel fusion partner and its products
|
US4764465A
(en)
*
|
1984-04-26 |
1988-08-16 |
Cetus Corporation |
Human monoclonal antibody against group A red blood cells
|
JPS6187630A
(ja)
*
|
1984-10-08 |
1986-05-06 |
Teijin Ltd |
単純ヘルペスウイルスに対するヒトモノクロ−ナル抗体及びその製造法
|
EP0198086B1
(en)
*
|
1984-09-28 |
1991-01-16 |
Teijin Limited |
Mouse human hybridoma producing antivirus human antibody, process for its preparation, and antivirus human monoclonal antibody
|
US4693975A
(en)
*
|
1984-11-20 |
1987-09-15 |
The Wistar Institute |
Human hybridroma fusion partner for production of human monoclonal antibodies
|
JPS61155398A
(ja)
*
|
1984-12-28 |
1986-07-15 |
Teijin Ltd |
抗緑膿菌ヒトモノクロ−ナル抗体及びその製造法並びにそれを有効成分とする治療剤
|
US4677070A
(en)
*
|
1985-04-26 |
1987-06-30 |
Cetus Corporation |
Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
|
USH1198H
(en)
|
1985-04-26 |
1993-06-01 |
Cetus Corporation |
Pseudomonas aeruginosa type-specific human monoclonal antibodies, their preparation and use
|
CH670098B
(it)
*
|
1985-05-23 |
1989-05-12 |
|
|
JPH0720885B2
(ja)
*
|
1985-09-27 |
1995-03-08 |
帝人株式会社 |
単純ヘルペスウイルス感染症の予防又は治療剤
|
NZ218499A
(en)
*
|
1985-12-10 |
1990-04-26 |
Genetic Systems Corp |
Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
|
AU613310B2
(en)
*
|
1986-04-01 |
1991-08-01 |
Genelabs Incorporated |
Immortalized virus-specific tissue cells
|
WO1987005929A1
(en)
*
|
1986-04-01 |
1987-10-08 |
Genelabs Incorporated |
Immortalized cells which produce tissue-specific products
|
US5565354A
(en)
*
|
1986-09-05 |
1996-10-15 |
Sandoz Ltd. |
Production of human monoclonal antibodies specific for hepatitis B surface antigen
|
US5646041A
(en)
*
|
1987-02-12 |
1997-07-08 |
Harfeldt; Elisabeth |
Monoclonal antibody to herpes simplex virus and cell line producing same
|
US5001065A
(en)
*
|
1987-05-27 |
1991-03-19 |
Cetus Corporation |
Human cell line and triomas, antibodies, and transformants derived therefrom
|
JPH01101896A
(ja)
*
|
1987-10-14 |
1989-04-19 |
Teijin Ltd |
カンジダに対するヒト・モノクローナル抗体とその製造法
|
US5215913A
(en)
*
|
1987-11-30 |
1993-06-01 |
Roger Williams General Hospital |
IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
|
IT1226477B
(it)
*
|
1988-07-04 |
1991-01-16 |
Genetik Mab S R L |
Linee cellulari n omas quale un mezzo per immortalare cellule produttrici di sostanze di qualunque specie animale.
|
US7041871B1
(en)
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5770429A
(en)
*
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
JP2535455B2
(ja)
*
|
1991-02-07 |
1996-09-18 |
帝人株式会社 |
サイトメガロウイルスに対するヒト・モノクロ―ナル抗体を産生するハイブリド―マ
|
IE922287A1
(en)
*
|
1991-07-15 |
1993-01-27 |
Wellcome Found |
Production of antibodies
|
JPH05276984A
(ja)
*
|
1991-09-05 |
1993-10-26 |
Teijin Ltd |
カンジダに対するヒト・モノクローナル抗体を産生するハイブリドーマ
|
JPH05260961A
(ja)
*
|
1992-05-21 |
1993-10-12 |
Teijin Ltd |
サイトメガロウイルスに対するヒト・モノクローナル抗体を産生するハイブリドーマ
|
DE69328135D1
(de)
*
|
1992-06-26 |
2000-04-27 |
Aetsrn |
Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren
|
EP0583980A1
(en)
*
|
1992-08-20 |
1994-02-23 |
Eli Lilly And Company |
Method for generating monoclonal antibodies from rabbits
|
WO1994011495A1
(en)
*
|
1992-11-06 |
1994-05-26 |
Sandoz, Ltd. |
Production of human monoclonal antibodies active against hepatitis b surface antigen
|
US5750106A
(en)
*
|
1993-01-28 |
1998-05-12 |
Novartis Ag |
Human monoclonal antibodies to cytomegalovirus
|
WO1997033617A1
(en)
*
|
1996-03-13 |
1997-09-18 |
Protein Design Labs, Inc. |
Fas ligand fusion proteins and their uses
|
WO1998035042A2
(en)
|
1997-02-07 |
1998-08-13 |
Us Gov Health & Human Serv |
Activity dependent neurotrophic factor iii (adnf iii)
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US6197582B1
(en)
|
1998-03-18 |
2001-03-06 |
The Trustees Of Columbia University In The City Of New York |
Development of human monoclonal antibodies and uses thereof
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
WO2001032712A2
(en)
*
|
1999-11-03 |
2001-05-10 |
Maxygen, Inc. |
Antibody diversity generation
|
US7060802B1
(en)
*
|
2000-09-18 |
2006-06-13 |
The Trustees Of Columbia University In The City Of New York |
Tumor-associated marker
|
PE20020574A1
(es)
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
DK2128246T3
(da)
|
2001-04-19 |
2014-05-12 |
Univ California |
Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
|
US7084257B2
(en)
*
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
WO2003030831A2
(en)
*
|
2001-10-11 |
2003-04-17 |
Protein Design Labs, Inc. |
Treatment of prostate cancer by inhibitors of atp synthase
|
EP1572121B1
(en)
|
2002-08-01 |
2012-01-11 |
The Regents of The University of California |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
|
US8506959B2
(en)
|
2002-11-01 |
2013-08-13 |
Neotope Biosciences Limited |
Prevention and treatment of synucleinopathic and amyloidogenic disease
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US7709610B2
(en)
|
2003-05-08 |
2010-05-04 |
Facet Biotech Corporation |
Therapeutic use of anti-CS1 antibodies
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
US7358331B2
(en)
|
2003-05-19 |
2008-04-15 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in Lewy body disease
|
CA2526900C
(en)
|
2003-05-19 |
2015-11-24 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in lewy body disease
|
WO2005018539A2
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
US7993872B2
(en)
|
2003-06-18 |
2011-08-09 |
The Scripps Research Institute |
Unnatural reactive amino acid genetic code additions
|
CA2822895A1
(en)
|
2004-05-25 |
2005-12-08 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
US7973134B2
(en)
*
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
EA013752B1
(ru)
|
2004-08-09 |
2010-06-30 |
Элан Фармасьютикалз, Инк. |
Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
|
US7935790B2
(en)
*
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
US7807789B2
(en)
*
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
EP2682126B1
(en)
|
2005-01-27 |
2016-11-23 |
Children's Hospital & Research Center at Oakland |
GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
|
CA2594297A1
(en)
|
2005-01-27 |
2006-07-27 |
The Regents Of The University Of California |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
|
ES2527503T3
(es)
|
2005-03-08 |
2015-01-26 |
Medimmune, Llc |
Virus influenza reordenantes
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
DE602006014691D1
(de)
*
|
2005-08-02 |
2010-07-15 |
Xbiotech Inc |
DIAGNOSE, BEHANDLUNG UND PRÄVENTION VON GEFÄSSERKRANKUNGEN MITTELS IL-1alpha-AUTOANTIKÖRPERN
|
WO2007027906A2
(en)
*
|
2005-08-31 |
2007-03-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
DOP2006000277A
(es)
|
2005-12-12 |
2007-08-31 |
Bayer Pharmaceuticals Corp |
Anticuerpos anti mn y métodos para su utilización
|
EP2003960B1
(en)
|
2006-03-31 |
2015-06-10 |
E. R. Squibb & Sons, L.L.C. |
Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
|
US8173425B2
(en)
*
|
2006-04-13 |
2012-05-08 |
N{dot over (a)}omasa Yamamoto |
Fusion partner cells
|
WO2007127335A2
(en)
*
|
2006-04-27 |
2007-11-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways
|
US20110008282A1
(en)
*
|
2006-05-15 |
2011-01-13 |
Xbiotech, Inc. |
IL-1alpha immunization induces autoantibodies protective against atherosclerosis
|
CN102580086A
(zh)
*
|
2006-05-22 |
2012-07-18 |
埃克斯生物科技公司 |
使用抗IL-1α抗体治疗癌症
|
EP2046809B1
(en)
|
2006-07-19 |
2016-12-07 |
The Trustees Of The University Of Pennsylvania |
Wsx-1/il-27 as a target for anti-inflammatory responses
|
US7939636B2
(en)
*
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
US9598462B2
(en)
|
2012-01-26 |
2017-03-21 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
US8080645B2
(en)
*
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
WO2008083169A2
(en)
*
|
2006-12-26 |
2008-07-10 |
The Johns Hopkins University |
Compositions and methods for the treatment of immunologic disorders
|
EP2586458B1
(en)
*
|
2006-12-27 |
2016-08-24 |
The Johns Hopkins University |
Compositions and methods for treating inflammation and auto-immune diseases
|
US20090142342A1
(en)
*
|
2006-12-27 |
2009-06-04 |
Johns Hopkins University |
B7-h4 receptor agonist compositions and methods for treating inflammation and auto-immune diseases
|
US7989173B2
(en)
*
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
JP5558834B2
(ja)
|
2007-02-23 |
2014-07-23 |
ヤンセン アルツハイマー イミュノセラピー |
シヌクレイノパチーおよびアミロイド形成疾患(amyloidogenicdisease)の予防および処置
|
LT3067066T
(lt)
|
2007-02-23 |
2019-06-25 |
Prothena Biosciences Limited |
Sinukleopatinių ir amiloidogeninių ligų prevencija ir gydymas
|
EP1972639A3
(en)
|
2007-03-07 |
2008-12-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
EP1975184A3
(en)
|
2007-03-26 |
2008-11-26 |
Cell Signaling Technology, Inc. |
Serine or threonine phosphorylation sites
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
EP1983003A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
EP1983002A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
WO2009020923A1
(en)
|
2007-08-03 |
2009-02-12 |
Musc Foundation For Research Development |
Human monoclonal antibodies and methods for producing the same
|
EP2178914A2
(en)
|
2007-08-15 |
2010-04-28 |
Bayer Schering Pharma Aktiengesellschaft |
Monospecific and multispecific antibodies and method of use
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
US8821885B2
(en)
|
2007-08-27 |
2014-09-02 |
Longhorn Vaccines & Diagnostics, Llc |
Immunogenic compositions and methods
|
WO2009085355A2
(en)
|
2007-10-01 |
2009-07-09 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection and transport system and methods of use
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
JP2010540953A
(ja)
|
2007-10-05 |
2010-12-24 |
ナショナル インスティテュート フォー バイオプロセッシング リサーチ アンド トレーニング リミテッド |
膵炎、敗血症および膵臓癌のためのグリコシル化マーカー
|
US20090203043A1
(en)
|
2007-11-21 |
2009-08-13 |
Peter Hornbeck |
Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways
|
US20090169549A1
(en)
*
|
2007-12-19 |
2009-07-02 |
The Board Of Regents Of The University Of Texas System |
Conformational isomers of alpha-synuclein, antibodies thereto and methods of their manufacture and use
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
EP2274437B1
(en)
|
2008-04-10 |
2015-12-23 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting egfr mutations in cancer
|
CN103656638B
(zh)
|
2008-05-30 |
2016-04-27 |
埃克斯生物科技公司 |
白细胞介素-1α抗体及使用方法
|
CN102112878A
(zh)
*
|
2008-06-06 |
2011-06-29 |
国立大学法人富山大学 |
用于检测流感病毒的装置
|
CA2730408A1
(en)
|
2008-07-11 |
2010-01-14 |
Chin-Fen Yang |
Influenza hemagglutinin and neuraminidase variants
|
CN102209557A
(zh)
*
|
2008-09-12 |
2011-10-05 |
埃克斯生物科技公司 |
靶向病原性单核细胞
|
US20100260752A1
(en)
|
2009-01-23 |
2010-10-14 |
Biosynexus Incorporated |
Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteria
|
EP2396033B1
(en)
|
2009-02-12 |
2016-09-28 |
MedImmune, LLC |
Influenza hemagglutinin and neuraminidase variants
|
US9309325B2
(en)
|
2009-05-07 |
2016-04-12 |
The Regents Of The University Of California |
Antibodies and methods of use thereof
|
US9005616B2
(en)
|
2009-08-31 |
2015-04-14 |
Amplimmune, Inc. |
Methods and compositions for the inhibition of transplant rejection
|
US8765432B2
(en)
|
2009-12-18 |
2014-07-01 |
Oligasis, Llc |
Targeted drug phosphorylcholine polymer conjugates
|
KR102167261B1
(ko)
|
2010-06-18 |
2020-10-20 |
엑스바이오테크, 인크. |
관절염 치료
|
KR102314003B1
(ko)
|
2010-08-23 |
2021-10-19 |
얀센 바이오테크 인코포레이티드 |
종양성 질병들에 대한 치료
|
KR20200145867A
(ko)
|
2010-12-06 |
2020-12-30 |
시애틀 지네틱스, 인크. |
Liv-1에 대한 인간화 항체 및 이의 암을 치료하기 위한 용도
|
JP6062918B2
(ja)
|
2011-04-01 |
2017-01-18 |
エックスバイオテク, インコーポレイテッドXbiotech, Inc. |
皮膚科的病理の治療
|
US9724409B2
(en)
|
2011-04-01 |
2017-08-08 |
Xbiotech, Inc. |
Treatment of inflammatory skin disease
|
ES2695102T3
(es)
|
2011-09-23 |
2019-01-02 |
Xbiotech Inc |
Tratamiento para la caquexia
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
UA105278C2
(ru)
|
2012-09-06 |
2014-04-25 |
Інститут Біології Клітини Нан України |
Способ получения каталитически активных антител (абзимов) с сиалидазной активностью
|
US9545441B2
(en)
|
2012-09-18 |
2017-01-17 |
Xbiotech, Inc. |
Treatment of diabetes
|
WO2014055544A1
(en)
|
2012-10-04 |
2014-04-10 |
Xbiotech, Inc. |
Treating vascular disease and complications thereof
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
SG11201506244VA
(en)
|
2013-03-13 |
2015-09-29 |
Prothena Biosciences Ltd |
Tau immunotherapy
|
EP3708189B1
(en)
|
2013-07-05 |
2023-11-29 |
University of Washington through its Center for Commercialization |
Soluble mic neutralizing monoclonal antibody for treating cancer
|
US9850302B2
(en)
|
2013-07-12 |
2017-12-26 |
Prothena Biosciences Limited |
Antibodies that recognize IAPP
|
US9951131B2
(en)
|
2013-07-12 |
2018-04-24 |
Prothena Biosciences Limited |
Antibodies that recognize IAPP
|
WO2015035342A2
(en)
|
2013-09-08 |
2015-03-12 |
Oligasis Llc |
Factor viii zwitterionic polymer conjugates
|
TW201623331A
(zh)
|
2014-03-12 |
2016-07-01 |
普羅帝納生物科學公司 |
抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
|
KR20160131082A
(ko)
|
2014-03-12 |
2016-11-15 |
프로테나 바이오사이언시즈 리미티드 |
Lg1-3에 특이적인 항-라미닌4 항체
|
KR20160131073A
(ko)
|
2014-03-12 |
2016-11-15 |
프로테나 바이오사이언시즈 리미티드 |
Lg4-5에 대해 특이적인 항-라미닌4 항체
|
ES2744526T3
(es)
|
2014-03-12 |
2020-02-25 |
Prothena Biosciences Ltd |
Anticuerpos anti-MCAM y métodos de uso asociados
|
JP6744856B2
(ja)
|
2014-04-08 |
2020-08-19 |
プロセナ・バイオサイエンシズ・リミテッド |
α−シヌクレインを認識する抗体を含む血液脳関門シャトル
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
US20160075772A1
(en)
|
2014-09-12 |
2016-03-17 |
Regeneron Pharmaceuticals, Inc. |
Treatment of Fibrodysplasia Ossificans Progressiva
|
EP3207128B1
(en)
|
2014-10-17 |
2022-07-27 |
Kodiak Sciences Inc. |
Butyrylcholinesterase zwitterionic polymer conjugates
|
TWI769570B
(zh)
|
2015-01-28 |
2022-07-01 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
TWI781507B
(zh)
|
2015-01-28 |
2022-10-21 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
TWI786505B
(zh)
|
2015-01-28 |
2022-12-11 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
CA2984249A1
(en)
|
2015-04-29 |
2016-11-03 |
Regeneron Pharmaceuticals, Inc. |
Treatment of fibrodysplasia ossificans progressiva
|
WO2016183292A1
(en)
|
2015-05-14 |
2016-11-17 |
Longhorn Vaccines And Diagnostics, Llc |
Rapid methods for the extraction of nucleic acids from biological samples
|
WO2017046776A2
(en)
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
WO2017046774A2
(en)
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
AU2016381964B2
(en)
|
2015-12-30 |
2024-02-15 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
WO2017149513A1
(en)
|
2016-03-03 |
2017-09-08 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
MY191649A
(en)
|
2016-03-04 |
2022-07-05 |
Jn Biosciences Llc |
Antibodies to tigit
|
WO2017153953A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
WO2017153955A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
BR112018072389A2
(pt)
|
2016-05-02 |
2019-02-19 |
Prothena Biosciences Limited |
anticorpos que reconhecem tau
|
PE20190208A1
(es)
|
2016-05-02 |
2019-02-07 |
Prothena Biosciences Ltd |
Anticuerpos que reconocen tau
|
WO2017208210A1
(en)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
JP7017013B2
(ja)
|
2016-07-02 |
2022-02-08 |
プロセナ バイオサイエンシーズ リミテッド |
抗トランスサイレチン抗体
|
WO2018007923A2
(en)
|
2016-07-02 |
2018-01-11 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
JP7076711B2
(ja)
|
2016-07-02 |
2022-05-30 |
プロセナ バイオサイエンシーズ リミテッド |
抗トランスサイレチン抗体
|
US20190227082A1
(en)
|
2016-07-06 |
2019-07-25 |
Prothena Biosciences Limited |
Assay for detecting total and s129 phosphorylated alpha-synuclein
|
MX2019009798A
(es)
|
2017-02-16 |
2020-01-30 |
Xbiotech Inc |
Tratamiento de la hidradenitis supurativa.
|
WO2018191548A2
(en)
|
2017-04-14 |
2018-10-18 |
Kodiak Sciences Inc. |
Complement factor d antagonist antibodies and conjugates thereof
|
SG11201910066QA
(en)
|
2017-05-02 |
2019-11-28 |
Prothena Biosciences Ltd |
Antibodies recognizing tau
|
WO2019018744A1
(en)
|
2017-07-21 |
2019-01-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
IMMUNOGENIC COMPOSITIONS OF NEISSERIA MENINGITIDIS
|
US11292846B2
(en)
|
2017-11-02 |
2022-04-05 |
Bayer Aktiengesellschaft |
Bispecific antibodies binding ALK-1 and BMPR-2
|
EP3886869A4
(en)
|
2018-11-28 |
2022-07-06 |
Forty Seven, Inc. |
GENETICALLY MODIFIED CSPH RESISTANT TO ABLATIVE TREATMENT
|
TW202045206A
(zh)
|
2019-02-27 |
2020-12-16 |
美商健生生物科技公司 |
抗體調配物
|
TW202100550A
(zh)
|
2019-03-03 |
2021-01-01 |
愛爾蘭商普羅帝納生物科學公司 |
識別tau之抗體
|
JP2022553640A
(ja)
|
2019-10-10 |
2022-12-26 |
コディアック サイエンシーズ インコーポレイテッド |
眼障害を処置する方法
|
WO2021142191A1
(en)
|
2020-01-08 |
2021-07-15 |
Regeneron Pharmaceuticals, Inc. |
Treatment of fibrodysplasia ossificans progressiva
|
WO2021211924A1
(en)
|
2020-04-16 |
2021-10-21 |
Janssen Biotech, Inc. |
Treatment of atopic dermatitis
|
PE20231078A1
(es)
|
2020-06-02 |
2023-07-17 |
Arcus Biosciences Inc |
Anticuerpos anti-tigit
|
AU2022210371A1
(en)
|
2021-01-22 |
2023-07-20 |
Bayer Aktiengesellschaft |
Lrrc15 antibodies and conjugates thereof
|